Heart–lung transplantation in patients with pulmonary atresia and ventricular septal defect Katarzyna Januszewska, MD, PhD, Edward Malec, MD, PhD, Gerd Juchem, MD, PhD, Ingo Kaczmarek, MD, PhD, Ralf Sodian, MD, PhD, Peter Uberfuhr, MD, PhD, Bruno Reichart, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 138, Issue 3, Pages 738-743 (September 2009) DOI: 10.1016/j.jtcvs.2008.12.054 Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions
Figure 1 Collateral vessels in patient 8: A, posterior aspect of the aorta showing MAPCAs (M) from the aortic arch and Waterstone shunt (W); B, anterior aspect of the aorta showing 3 MAPCAs (3M) from the descending aorta. The Journal of Thoracic and Cardiovascular Surgery 2009 138, 738-743DOI: (10.1016/j.jtcvs.2008.12.054) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions
Figure 2 Actuarial survival after heart–lung transplantation (HLTx) in patients with pulmonary atresia and ventricular septal defect (PA+VSD) in comparison with the whole group of HLTx recipients in our institution (All). The Journal of Thoracic and Cardiovascular Surgery 2009 138, 738-743DOI: (10.1016/j.jtcvs.2008.12.054) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions